A. Santucci

发表

Competing risk analysis using R: an easy guide for clinicians

F. Aversa, L. Scrucca, A. Santucci, 2007, Bone Marrow Transplantation.

Allogeneic stem cell transplantation for patients with advanced rhabdomyosarcoma: a retrospective assessment

P. Rohrlich, P. Antunović, S. Burdach, 2013, British Journal of Cancer.

Meformin, plasma glucose and free fatty acids in type II diabetic out-patients: results of a clinical study.

S. Manfrini, P. Filipponi, A. Santucci, 1997, Diabetes research and clinical practice.

Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype.

Paola Fazi, Marco Vignetti, Natalia Meani, 2005, The New England journal of medicine.

NPM1 Deletion Is Associated with Gross Chromosomal Rearrangements in Leukemia

A. Aventín, B. Falini, Valeria Nofrini, 2010, PloS one.

Mediastinal large B‐cell lymphoma: clinical and immunohistological findings in 18 patients treated with different third‐generation regimens

S. Pileri, L. Pasqualucci, F. Gherlinzoni, 1995, British journal of haematology.

Graft engineering for allogeneic haploidentical stem cell transplantation.

M. Martelli, F. Aversa, A. Tabilio, 2004, Blood cells, molecules & diseases.

Induction chemotherapy plus high-dose radiotherapy versus radiotherapy alone in locally advanced unresectable non-small-cell lung cancer.

L. Crinò, M. Tonato, E. Maranzano, 1993, Annals of oncology : official journal of the European Society for Medical Oncology.

Cisplatin-gemcitabine combination in advanced non-small-cell lung cancer: a phase II study.

G. Scagliotti, F. de Marinis, L. Crinò, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cisplatin (CDDP)-etoposide VS DCCP-mitomycin-vindesine VS CDDP-mitomycin-iphosphamide in advanced non small cell lung cancer (NSCLC). A prospective randomized trial of the Italian oncology group for clinical research. (GOIRC)

L. Crinò, C. Boni, M. Clerici, 1993 .

Bactericidal activity of oxacillin and glycopeptides against Staphylococcus aureus in patients with endocarditis: Looking for a relationship between tolerance and outcome

F. Baldelli, A. Raglio, A. Santucci, 2011, Annals of Clinical Microbiology and Antimicrobials.

In haematopoietic SCT for acute leukemia TBI impacts on relapse but not survival: results of a multicentre observational study

R. Corvò, F. Aversa, F. Locatelli, 2013, Bone Marrow Transplantation.

Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse.

C. Mecucci, M. Martelli, L. Ruggeri, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Improved outcome with T-cell-depleted bone marrow transplantation for acute leukemia.

M. Martelli, F. Aversa, I. Cunningham, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

In Vivo Demethylation of a MoMuLV Retroviral Vector Expressing the Herpes Simplex Thymidine Kinase Suicide Gene by 5′ Azacytidine

M. Martelli, A. Tabilio, K. Fettucciari, 2000, Stem cells.

Multilineage dysplasia has no impact on biologic, clinicopathologic, and prognostic features of AML with mutated nucleophosmin (NPM1).

Paola Fazi, Marco Vignetti, Hans-Ulrich Klein, 2010, Blood.

AML with mutated NPM1 carrying a normal or aberrant karyotype show overlapping biologic, pathologic, immunophenotypic, and prognostic features.

A. Kohlmann, T. Haferlach, M. Vignetti, 2009, Blood.

Lymphoma: Clinico-Pathological Findings and Outcome + ALK

S. Pileri, C. Wolf‐Peeters, B. Falini, 2010 .

Lymphomas expressing ALK fusion protein(s) other than NPM-ALK.

E. Campo, G. Ott, S. Pileri, 1999, Blood.

ALK+ lymphoma: clinico-pathological findings and outcome.

S. Pileri, C. Wolf‐Peeters, B. Falini, 1999, Blood.

Lymphoma : Clinico-Pathological Findings and Outcome

S. Pileri, C. Wolf‐Peeters, B. Falini, 1999 .

Hematopoietic stem cell transplantation from alternative donors for high-risk acute leukemia: the haploidentical option.

M. Martelli, F. Aversa, A. Velardi, 2007, Current stem cell research & therapy.

Regression modeling of competing risk using R: an in depth guide for clinicians

F. Aversa, L. Scrucca, A. Santucci, 2010, Bone Marrow Transplantation.

In haematopoietic SCT for acute leukemia TBI impacts on relapse but not survival: results of a multicentre observational study

R. Corvò, F. Aversa, F. Locatelli, 2013, Bone Marrow Transplantation.

Cataracts in patients receiving stem cell transplantation after conditioning with total body irradiation

F. Aversa, A. Santucci, C. Cagini, 2002, Bone Marrow Transplantation.

No improvement of survival with reduced- versus high-intensity conditioning for allogeneic stem cell transplants in Ewing tumor patients.

U. Dirksen, A. Borkhardt, G. Dini, 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

Cytoplasmic mutated nucleophosmin (NPM) defines the molecular status of a significant fraction of myeloid sarcomas

S. Pileri, H. Stein, N. Bolli, 2007, Leukemia.

Mild hyperhomocysteinemia is a risk-factor in all etiological subtypes of stroke

L. Parnetti, V. Caso, T. Bottiglieri, 2004, Neurological Sciences.

In Vitro Chemosensitivity of Newly Diagnosed and Relapsing Acute Non-Lymphoid Leukemia Patients

E. Lepri, A. Santucci, M. Liberati, 1991, Tumori.

[5 days Cefaclor vs. 10 days amoxicillin/clavulanate in the treatment of childhood streptococcal pharyngitis. Data from a randomized clinical trial].

G. Mele, G. Bottaro, E. Napoleone, 2012, Minerva pediatrica.

Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype.

M. Martelli, L. Ruggeri, F. Aversa, 1998, The New England journal of medicine.